Swedish Orphan Biovitrum Stock Buy Hold or Sell Recommendation
| BIOVF Stock | USD 22.87 2.13 8.52% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Swedish Orphan Biovitrum is 'Hold'. Macroaxis provides Swedish Orphan buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BIOVF positions. The advice algorithm takes into account all of Swedish Orphan's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Swedish Orphan's buy or sell advice are summarized below:
Real Value 20.24 | Hype Value 22.87 | Market Value 22.87 | Naive Value 25.63 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Swedish Orphan Biovitrum given historical horizon and risk tolerance towards Swedish Orphan. When Macroaxis issues a 'buy' or 'sell' recommendation for Swedish Orphan Biovitrum, the advice is generated through an automated system that utilizes algorithms and statistical models.
Swedish |
Execute Swedish Orphan Buy or Sell Advice
The Swedish recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Swedish Orphan Biovitrum. Macroaxis does not own or have any residual interests in Swedish Orphan Biovitrum or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Swedish Orphan's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Swedish Orphan Trading Alerts and Improvement Suggestions
| Swedish Orphan generated a negative expected return over the last 90 days | |
| Swedish Orphan has high historical volatility and very poor performance | |
| About 71.0% of the company shares are held by institutions such as insurance companies |
Swedish Orphan Returns Distribution Density
The distribution of Swedish Orphan's historical returns is an attempt to chart the uncertainty of Swedish Orphan's future price movements. The chart of the probability distribution of Swedish Orphan daily returns describes the distribution of returns around its average expected value. We use Swedish Orphan Biovitrum price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Swedish Orphan returns is essential to provide solid investment advice for Swedish Orphan.
| Mean Return | -0.21 | Value At Risk | -6.86 | Potential Upside | 2.28 | Standard Deviation | 2.98 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Swedish Orphan historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Swedish Orphan Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Swedish Orphan or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Swedish Orphan's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Swedish pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.3 | |
β | Beta against NYSE Composite | 1.50 | |
σ | Overall volatility | 3.07 | |
Ir | Information ratio | -0.09 |
Swedish Orphan Volatility Alert
Swedish Orphan Biovitrum exhibits very low volatility with skewness of -0.93 and kurtosis of 10.26. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Swedish Orphan's pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Swedish Orphan's pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Swedish Orphan Fundamentals Vs Peers
Comparing Swedish Orphan's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Swedish Orphan's direct or indirect competition across all of the common fundamentals between Swedish Orphan and the related equities. This way, we can detect undervalued stocks with similar characteristics as Swedish Orphan or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Swedish Orphan's fundamental indicators could also be used in its relative valuation, which is a method of valuing Swedish Orphan by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Swedish Orphan to competition |
| Fundamentals | Swedish Orphan | Peer Average |
| Return On Equity | 0.11 | -0.31 |
| Return On Asset | 0.0555 | -0.14 |
| Profit Margin | 0.14 % | (1.27) % |
| Current Valuation | 7.05 B | 16.62 B |
| Shares Outstanding | 295.99 M | 571.82 M |
| Shares Owned By Insiders | 4.00 % | 10.09 % |
| Shares Owned By Institutions | 70.55 % | 39.21 % |
| Price To Earning | 20.33 X | 28.72 X |
| Price To Book | 2.58 X | 9.51 X |
| Price To Sales | 3.68 X | 11.42 X |
| Revenue | 15.53 B | 9.43 B |
| Gross Profit | 14.38 B | 27.38 B |
| EBITDA | 5.72 B | 3.9 B |
| Net Income | 2.68 B | 570.98 M |
| Cash And Equivalents | 280.15 M | 2.7 B |
| Cash Per Share | 1.04 X | 5.01 X |
| Total Debt | 8.78 B | 5.32 B |
| Debt To Equity | 0.41 % | 48.70 % |
| Current Ratio | 1.02 X | 2.16 X |
| Book Value Per Share | 3.55 X | 1.93 K |
| Cash Flow From Operations | 5.47 B | 971.22 M |
| Earnings Per Share | 0.98 X | 3.12 X |
| Price To Earnings To Growth | 34.30 X | 4.89 X |
| Number Of Employees | 1.56 K | 18.84 K |
| Beta | 0.39 | -0.15 |
| Market Capitalization | 6.99 B | 19.03 B |
| Total Asset | 48.66 B | 29.47 B |
| Working Capital | 1.16 B | 1.48 B |
| Current Asset | 2.65 B | 9.34 B |
| Current Liabilities | 1.49 B | 7.9 B |
| Net Asset | 48.66 B |
Swedish Orphan Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Swedish . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Swedish Orphan Buy or Sell Advice
When is the right time to buy or sell Swedish Orphan Biovitrum? Buying financial instruments such as Swedish Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Swedish Orphan in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Financials ETFs Thematic Idea Now
Financials ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Financials ETFs theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Swedish Orphan Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Swedish Pink Sheet analysis
When running Swedish Orphan's price analysis, check to measure Swedish Orphan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Swedish Orphan is operating at the current time. Most of Swedish Orphan's value examination focuses on studying past and present price action to predict the probability of Swedish Orphan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Swedish Orphan's price. Additionally, you may evaluate how the addition of Swedish Orphan to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |